About the Authors
- Hae-Jung Park
-
Affiliation International Vaccine Institute, Seoul, Korea
- Boris Ferko
-
Affiliation AVIR Green Hills Biotechnology AG, Vienna, Austria
- Young-Ho Byun
-
Affiliation Department of Biotechnology and Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea
- Joo-Hye Song
-
Affiliation International Vaccine Institute, Seoul, Korea
- Gye-Yeong Han
-
Affiliation International Vaccine Institute, Seoul, Korea
- Elisabeth Roethl
-
Affiliation AVIR Green Hills Biotechnology AG, Vienna, Austria
- Andrej Egorov
-
Affiliation AVIR Green Hills Biotechnology AG, Vienna, Austria
- Thomas Muster
-
Affiliation AVIR Green Hills Biotechnology AG, Vienna, Austria
- Baiklin Seong
-
Affiliation Department of Biotechnology and Translational Research Center for Protein Function Control, Yonsei University, Seoul, Korea
- Mi-Na Kweon
-
Affiliation International Vaccine Institute, Seoul, Korea
- Manki Song
-
Affiliation International Vaccine Institute, Seoul, Korea
- Cecil Czerkinsky
-
Affiliation International Vaccine Institute, Seoul, Korea
- Huan H. Nguyen
-
* E-mail: hhnguyen@ivi.int
Affiliation International Vaccine Institute, Seoul, Korea
Competing Interests
BF, ER, AE, and TM were employees of Avir Green Hills Biotechnology (AGHB) AG, Vienna, Austria at the time of study. IPR rights related to this manuscript are covered by the following IP rights: DelNs1 mutants are covered by patents from AGHB and Mount Sinai School of Medicine. Patent applications covering the technology platform of the influenza virus and virus amplification procedure are fully owned by AGHB (US 8,057,803 B2 and the publication day is Feb. 26, 2009.) In adherence to the PLoS guidelines, AGHB will make freely available any materials and information described in the publication that are reasonably requested by others for the purpose of academic, non-commercial research. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: HHN CC BF AE. Performed the experiments: HJP YHB JHS GYH BF ER. Analyzed the data: HHN HJP BF AE CC MKS TM. Contributed reagents/materials/analysis tools: MNK BS MKS TM. Wrote the paper: HHN HJP CC BF AE.